
New Treatment Option for Advanced Liver Cancer Tops SPT Week in Review
Top news of the week from Specialty Pharmacy Times.
5. FDA Grants Breakthrough Designation to Mantle Cell Lymphoma Treatment
Zanubrutinib (BGB-3111) is being investigated for the treatment of various B-cell malignancies, including mantle cell lymphoma.
4. House Committee Investigating Prescription Drug Pricing Practices
The committee is seeking detailed information and documents about some pharmaceutical companies' prescription drug pricing practices.
3. FDA OKs Generic Vigabatrin Tablets for Seizures
Vigabatrin, which is also sold under the brand name Sabril, is used to treat complex partial seizures in adult and pediatric patients.
2. Walmart Leaving CVS Pharmacy Networks Over Reimbursement Dispute
Officials with CVS Health have announced that Walmart has opted to leave CVS Caremark pharmacy benefit management commercial and Managed Medicaid retail pharmacy networks.
1. FDA OKs Cabozantinib for Previously-Treated Hepatocellular Carcinoma
Cabozantinib’s new indication provides an additional therapeutic option for patients with advanced liver cancer who have been previously treated with sorafenib.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.